{"id":1005176,"date":"2026-09-22T13:12:08","date_gmt":"2026-09-22T17:12:08","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/suewallst-reminds-shareholders-of-a-lead-plaintiff-deadline-of-october-27-2026-in-innventure-inc-lawsuit-inv\/"},"modified":"2026-09-22T13:12:08","modified_gmt":"2026-09-22T17:12:08","slug":"suewallst-reminds-shareholders-of-a-lead-plaintiff-deadline-of-october-27-2026-in-innventure-inc-lawsuit-inv","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/suewallst-reminds-shareholders-of-a-lead-plaintiff-deadline-of-october-27-2026-in-innventure-inc-lawsuit-inv\/","title":{"rendered":"SueWallSt Reminds Shareholders of a Lead Plaintiff Deadline of October 27, 2026 in Innventure, Inc. Lawsuit – INV"},"content":{"rendered":"

\nNotice to pension funds, asset managers, and fiduciaries: a securities class action alleges Innventure’s flagship 300MW AI data center agreement rested on a counterparty later described in a research report as a shell company, ahead of a 55% single-day collapse in INV shares
\n<\/h2>\n
\n

NEW YORK, Sept. 22, 2026 (GLOBE NEWSWIRE) — SueWallSt notifies institutional investors in Innventure, Inc. (NASDAQ: INV) that a class action lawsuit has been filed on behalf of shareholders who purchased securities between November 17, 2025 and August 13, 2026.\u00a0Find out if you qualify to recover losses<\/a>. You may also contact Joseph E. Levi, Esq. at jlevi@SueWallSt.com<\/a> or (888) SueWallSt.<\/p>\n

INV shares fell $1.98 per share, or 55%, to close at $1.62 on August 14, 2026, on unusually heavy trading volume. Funds holding blocks acquired across the Class Period may carry realized or mark-to-market losses well into seven figures. To be considered for lead plaintiff, investors must file by October 27, 2026.<\/p>\n

\n Notice to Institutional Holders<\/strong>\n <\/p>\n

Innventure’s valuation was concentrated in a single asset. The complaint charges that one analyst estimated the Company’s stake in Accelsius accounted for roughly 77% of Innventure’s approximately $540 million valuation, and that public statements tied Accelsius’ 2026 outlook to a deployment agreement announced in November 2025.<\/p>\n

\n Portfolio Impact Assessment<\/strong>\n <\/p>\n

As averred in the pleading, that agreement was later removed from internal bookings, and the Company suspended its previously communicated 2026 revenue and cash flow expectations for Accelsius while reporting a quarterly net loss of $34.9 million. Concentrated single-asset exposure means the repricing was absorbed disproportionately by holders who accumulated positions after the announcement.<\/p>\n

\n Fiduciary Obligations and Recovery Options<\/strong>\n <\/p>\n